The above diagram shows the color scheme of the layout in the main result page.
The parent entities and officers are those entities,
including individual and legal
persons, have significant controls over the company in focus. The offspring entities and appointments are
those entities that the
company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in
focus and show upstream or downstream connections. In general, ascendant
entities can be found by moving toward upstream, and descendant entities
are by toward downstream. In this way, progenitor entities such
as grandparent companies (parents of parent),
sibling companies (children of parent),
partner companies (parents of child), and
progeny entities such as grandchild companies (children of child)
can be found easily.
Insolvency (Case 1) Members voluntary liquidation Commencement of winding up on 2021-03-02 during the appointment or period of control Due to be dissolved on 2026-05-12 during the appointment or period of control
102, High Street, Godalming, England
Liquidation Corporate (11 parents, 2 offsprings)
Person with significant control
2019-09-04 ~ now
PE - Ownership of voting rights - 75% or more → CIF 0
PE - Ownership of shares – 75% or more → CIF 0
Company in focus
ASPIRE PHARMA HOLDINGS LIMITED
Period: 2014-11-11 ~ now
Company number: 09306251
Registered name
ASPIRE PHARMA HOLDINGS LIMITED - now
Insolvency (Case 1) Members voluntary liquidation Declaration of solvency sworn on 2021-02-26 Commencement of winding up on 2021-03-02
Standard Industrial Classification
46460 - Wholesale Of Pharmaceutical Goods
Brief company account
Please be reminded the displayed account data is older than 4 years hence might not reflect current company status.
Fixed Assets - Investments
3,858,549 GBP2020-12-31
2,358,591 GBP2019-12-31
Debtors
215 GBP2020-12-31
215 GBP2019-12-31
Cash at bank and in hand
238,145 GBP2020-12-31
417,166 GBP2019-12-31
Current Assets
238,360 GBP2020-12-31
417,381 GBP2019-12-31
Creditors
Current, Amounts falling due within one year
-12,461 GBP2020-12-31
-156,599 GBP2019-12-31
Net Current Assets/Liabilities
225,899 GBP2020-12-31
260,782 GBP2019-12-31
Total Assets Less Current Liabilities
4,084,448 GBP2020-12-31
2,619,373 GBP2019-12-31
Creditors
Non-current, Amounts falling due after one year
-1,532,363 GBP2020-12-31
0 GBP2019-12-31
Net Assets/Liabilities
2,552,085 GBP2020-12-31
2,619,373 GBP2019-12-31
Equity
Called up share capital
2 GBP2020-12-31
2 GBP2019-12-31
Retained earnings (accumulated losses)
2,552,083 GBP2020-12-31
2,619,371 GBP2019-12-31
Equity
2,552,085 GBP2020-12-31
2,619,373 GBP2019-12-31
Average Number of Employees
52020-01-01 ~ 2020-12-31
Investments in group undertakings and participating interests
3,858,549 GBP2020-12-31
2,358,591 GBP2019-12-31
Amounts Owed By Related Parties
215 GBP2020-12-31
Current
215 GBP2019-12-31
Amounts owed to group undertakings
Current
100 GBP2020-12-31
0 GBP2019-12-31
Other Creditors
Current
12,361 GBP2020-12-31
156,599 GBP2019-12-31
Creditors
Current
12,461 GBP2020-12-31
156,599 GBP2019-12-31
Other Creditors
Non-current
1,532,363 GBP2020-12-31
0 GBP2019-12-31
Equity
Called up share capital
2 GBP2020-12-31
2 GBP2019-12-31
Related profiles found in government register
ASPIRE PHARMA HOLDINGS LIMITED
Info
Registered number 09306251
6th Floor, 2 London Wall Place, London EC2Y 5AU
PRIVATE LIMITED COMPANY incorporated on 2014-11-11 (11 years 7 months). The status of the company number is Liquidation.
The last date of confirmation statement was made at 2021-08-28
CIF 0
ASPIRE PHARMA HOLDINGS LIMITED
S
Registered number missing
102, High Street, Godalmin, Surrey, United Kingdom, GU7 1DS
Insolvency (Case 1) Members voluntary liquidation Commencement of winding up on 2021-03-02 during the appointment or period of control Dissolved on 2025-05-28 during the appointment or period of control
6th Floor 2 London Wall Place, London
Dissolved Corporate (9 parents)
Person with significant control
2018-03-28 ~ 2019-09-16
CIF 3 - Ownership of voting rights - More than 50% but less than 75% → OE
CIF 3 - Ownership of shares – More than 50% but less than 75% → OE
2017-07-18 ~ dissolved
CIF 1 - Ownership of voting rights - 75% or more → OE